ALLOGENEIC CORD BLOOD TRANSPLANTATION IN CHILDREN WITH HEMATOLOGICAL MALIGNANCIES: A Long-Term Follow-Up Single-Center Study

REFERENCES

• Gluckman E, Broxmeyer H A, Auerbach A D, et al. Hematopoietic reconstitution in patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989; 32: 1174–1178
   Google Scholar
• Wagner J E, Kernan N A, Steinbuch M, et al. Allogeneic sibling umbilical cord blood transplantation in children with malignant and non-malignant disease. Lancet 1995; 346: 214–219
   PubMed Web of Science ®Google Scholar
• Brunstein C G, Setubal D C, Wagner J E. Expanding the role of umbilical cord blood transplantation. Br J Haematol 2007; 137: 20–35
   Google Scholar
• Dalle J H, Duval M, Moghrabi A, et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 2004; 33: 605–611
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577
   PubMed Web of Science ®Google Scholar
• Wagner J E, Barker J N, DeFor T E, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618
   PubMed Web of Science ®Google Scholar
• Eapen M, Rubinstein P, Zhang M J, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet 2007; 369: 1947–1954
   PubMed Web of Science ®Google Scholar
• Laughlin M J, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822
   PubMed Web of Science ®Google Scholar
• Benito A I, Diaz M A, Gonzalez-Vicent M, et al. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant 2004; 33: 675–690
   Google Scholar
• Sanz G F, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematological malignancies. Blood 2001; 98: 2332–2338
   PubMed Web of Science ®Google Scholar
• Tse W, Bunting K D, Laughlin M. New insights into cord blood stem cell transplantation. Curr Opin Hematol 2008; 15: 279–284
   PubMed Web of Science ®Google Scholar
• Moretta A, Maccario R, Fagioli F, et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29: 371–379
   PubMed Web of Science ®Google Scholar
• Szabolcs P, Niedzwiecki D. Immune reconstitution in children after unrelated cord blood transplantation. Biol Blood Marrow Transplant 2008; 14: 66–72
   PubMed Web of Science ®Google Scholar
• Szabolcs P, Park K D, Reese M, et al. Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp Hematol 2003; 31: 708–714
   PubMed Web of Science ®Google Scholar
• Komanduri K V, St John L S, de Lima M, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007; 110: 4543–4551
   PubMed Web of Science ®Google Scholar
• Cohen G, Carter S L, Weinberg K I, et al. Antigen-specific T-lymphocyte function after cord blood transplantation. Biol Blood Marrow Transplant 2006; 12: 1335–1342
   PubMedGoogle Scholar
• Laughlin M J, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–2275
   PubMed Web of Science ®Google Scholar
• La Motte-Mohs R, Herer E, Zuñiga-Plfucker J C. Induction of T-cell development from human cord hematopoietic stem cells by Delta-like 1 in vitro. Blood 2005; 105: 1431–1439
   PubMed Web of Science ®Google Scholar
• Rocha V, Cornish J, Sievers E L, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2971
   PubMed Web of Science ®Google Scholar
• Lang P, Handgretinger R, Niethammer D, et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood 2003; 101: 1630–1636
   PubMed Web of Science ®Google Scholar
• Michel G, Rocha V, Chevret S, et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord group analysis. Blood 2003; 102: 4290–4297
   PubMedGoogle Scholar
• Styczynski J, Cheung Y-K, Garvin J, et al. Outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant. 2004; 34: 129–136
   Google Scholar
• Bradley M B, Salwani P, Baldinger L, et al. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant disease. Bone Marrow Transplant 2007; 40: 621–631
   PubMed Web of Science ®Google Scholar
• Willemze R, Arrais C, Labopin M, et al. Inhibitory KIR-ligand mismatching is associated with decreased incidence of relapse and improved disease-free survival after unrelated cord blood stem cell transplantation for patients with acute leukemia. Bone Marrow Transplant 2008; 41(Suppl 1): O83)
   Google Scholar
• Gluckman E, Rocha V. Indications and results of cord blood transplant in children with leukemia. Bone Marrow Transplant 2008; 41: S80–S82
   Web of Science ®Google Scholar